Legal & General Group PLC Geron Corp Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Geron Corp stock. As of the latest transaction made, Legal & General Group PLC holds 508,872 shares of GERN stock, worth $814,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares

508,872

Previous 496,332 2.53%

Holding current value

$814,195

Previous $2.25 Million 20.06%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.3 - $4.44 $41,382 - $55,677	12,540 Added 2.53%	508,872 $1.8 Million
Q3 2024 Feb 28, 2025	SELL	$4.17 - $4.99 $242,051 - $289,649	-58,046 Reduced 11.41%	450,826 $2.05 Million
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $230,463 - $275,782	55,267 Added 12.53%	496,332 $2.25 Million
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $139,540 - $229,116	45,013 Added 11.37%	441,065 $1.87 Million
Q1 2024 May 14, 2024	SELL	$1.75 - $3.44 $25,147 - $49,432	-14,370 Reduced 3.5%	396,052 $1.31 Million
Q4 2023 Feb 15, 2024	BUY	$1.74 - $2.31 $553 - $734	318 Added 0.08%	410,422 $865,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $15,464 - $24,039	7,329 Added 1.82%	410,104 $869,000
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $448,027 - $839,198	227,425 Added 129.7%	402,775 $1.29 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $60,285 - $95,781	28,171 Added 19.14%	175,350 $380,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $10,795 - $12,869	5,318 Added 3.75%	147,179 $356,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $7,748 - $13,641	4,640 Added 3.38%	141,861 $332,000
Q2 2022 Aug 22, 2022	BUY	$1.19 - $1.65 $37,592 - $52,123	31,590 Added 29.91%	137,221 $213,000
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $56,658 - $70,822	47,215 Added 80.83%	105,631 $144,000
Q2 2021 Aug 12, 2021	SELL	$1.25 - $1.83 $5,143 - $7,530	-4,115 Reduced 6.58%	58,416 $83,000
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $6,254 - $8,641	4,115 Added 7.04%	62,531 $100,000
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $23,288 - $32,076	14,647 Added 33.46%	58,416 $102,000
Q1 2020 May 14, 2020	SELL	$0.89 - $1.49 $5,429 - $9,090	-6,101 Reduced 12.23%	43,769 $52,000
Q3 2019 Nov 13, 2019	BUY	$1.15 - $1.59 $18,103 - $25,029	15,742 Added 46.13%	49,870 $67,000
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $5,246 - $9,506	5,195 Added 17.96%	34,128 $57,000
Q3 2018 Nov 20, 2018	BUY	$1.76 - $6.38 $9,037 - $32,761	5,135 Added 21.58%	28,933 $50,000
Q2 2018 Aug 10, 2018	SELL	$3.29 - $4.82 $3,546 - $5,195	-1,078 Reduced 4.33%	23,798 $82,000
Q1 2018 May 17, 2018	SELL	$1.81 - $5.98 $22,896 - $75,647	-12,650 Reduced 33.71%	24,876 $106,000
Q4 2017 Feb 13, 2018	BUY	$1.8 - $2.32 $67,546 - $87,060	37,526	37,526 $68,000

Others Institutions Holding GERN

# of Institutions

306

Shares Held

465M

Call Options Held

1.07M

Put Options Held

648K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $605M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Geron Corp Transaction History